Fine Organic Industries announces Q2 & H1 FY26 results and strategic US expansion in Investor Presentation
Fine Organic Industries released its Investor Presentation for Q2 & H1 FY26, showing a slight dip in Q2 YoY financials but stable demand. Key strategic moves include a US subsidiary, land acquisition for expansion, and equity infusion.
The announcement provides comprehensive financial and operational updates, including strategic global expansion plans and equity infusion, which are significant for the company's future trajectory. However, the current quarter's financial performance shows a slight dip, balancing the immediate market impact.
While strategic expansions in the US and equity infusion are positive for long-term growth, the immediate financial results for Q2 FY26 and H1 FY26 show a slight year-on-year decline in revenue, EBITDA, and PAT, partly due to increased raw material costs.
* Fine Organic Industries Limited has released its Investor Presentation for November 2025, detailing business highlights and financial performance for Q2 FY26 and H1 FY26. * For Q2 FY26 (Standalone): * Revenue from Operations stood at ₹571.9 crore, a 4.0% decrease YoY. * EBITDA was ₹108.3 crore, down 24.3% YoY. * Profit After Tax (PAT) was ₹95.3 crore, a 15.7% decrease YoY. * For H1 FY26 (Standalone): * Revenue from Operations increased by 2.5% YoY to ₹1,131.1 crore. * EBITDA was ₹215.5 crore, an 18.7% decrease YoY. * PAT was ₹188.2 crore, an 11.3% decrease YoY. * For Q2 FY26 (Consolidated): * Revenue from Operations was ₹597.3 crore, a slight 0.2% increase YoY. * EBITDA was ₹135.2 crore, down 10.3% YoY. * PAT was ₹108.5 crore, a 7.6% decrease YoY. * For H1 FY26 (Consolidated): * Revenue from Operations increased by 3.5% YoY to ₹1,185.7 crore. * EBITDA was ₹258.7 crore, an 11.0% decrease YoY. * PAT was ₹225.7 crore, a 2.2% decrease YoY. * Business Highlights for Q2 & H1 FY26: * Exports accounted for 55% of total revenue in Q2 FY26 and H1 FY26, with overall demand remaining stable and domestic demand improving in Q2. * Raw material costs increased in H1 FY26 compared to H1 FY25, with a slight increase in Q2 compared to Q1. * The Wholly Owned Subsidiary (WOS) Company issued Preference Shares amounting to ₹65 crore as part of its equity capital structure during the quarter. * Strategic Expansion in the United States: The Company incorporated a wholly owned subsidiary, Fine Organics Americas LLC, and made an equity investment of USD 1.12 million (₹ ~9.6 crore) in June 2025. In July 2025, the Company acquired approximately 159.9 acres of land in Jonesville, Union County, South Carolina, for future expansion and manufacturing capabilities. * The presentation highlighted Fine Organic's expertise in oleochemistry, focus on green additives, strong R&D, diversified product portfolio, specialized business model with high entry barriers, and an experienced management team.
What to do with a filing like this
Fine Organic Industries Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fine Organic Industries Limited. Read the original for the full detail.